Mono-deuterated, 15-hydroxyprostaglandins

Details Mono-deuterated, 15-hydroxyprostaglandins Mono-deuterated, 15-hydroxyprostaglandins

C - Chemistry, Metallurgy

07

D

260/235.01, 260/

C07D 457/06 (2006.01) A61K 31/045 (2006.01) A61K 31/19 (2006.01) A61K 31/20 (2006.01) A61K 31/215 (2006.01) A61K 31/23 (2006.01) A61K 31/395 (2006.01) A61K 31/41 (2006.01) A61K 31/415 (2006.01) A61K 31/475 (2006.01) C07D 233/60 (2006.01) C07D 257/04 (2006.01) C07D 307/77 (2006.01) C07D 307/93 (2006.01) C07D 403/08 (2006.01) C07D 405/14 (2006.01) C07D 457/00 (2006.01) C07D 457/04 (2006.01)

Patent

CA 1095032

Abstract of the Disclosure This invention provides new mono-deuterated prostaglandins having prolonged uterotonic activity.

255572

Affiliated with

Also associated with

Rating

Mono-deuterated, 15-hydroxyprostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mono-deuterated, 15-hydroxyprostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mono-deuterated, 15-hydroxyprostaglandins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-14160